Effect of cilnidipine, a novel dihydropyridine Ca2+ channel blocker, on adrenal catecholamine secretion in anesthetized dogs

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 3, 1998, Pages 479-484

  Nagayama, Takahiro ^a   Yoshida, Makoto ^a   Suzuki Kusaba, Mizue ^a   Hisa, Hiroaki ^a   Kimura, Tomohiko ^b   Satoh, Susumu ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b NIPPON DENTAL UNIVERSITY   (Japan)

Author keywords

Acetylcholine; Adrenal catecholamine; Cilnidipine; L type and N type voltage dependent Ca2+ channels; Nifedipine; Splanchnic nerve stimulation

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; ACETYLCHOLINE; ADRENALIN; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; CILNIDIPINE; DIHYDROPYRIDINE; MUSCARINE; NIFEDIPINE; NORADRENALIN;

ADRENALIN RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATECHOLAMINE RELEASE; CHROMAFFIN CELL; DOG; DRUG EFFECT; NONHUMAN; NORADRENALIN RELEASE; PRESSOR RESPONSE; PRIORITY JOURNAL; RECEPTOR BLOCKING; SPLANCHNIC NERVE;

ACETYLCHOLINE; ADRENAL GLANDS; ANIMALS; CALCIUM CHANNEL BLOCKERS; CATECHOLAMINES; DIHYDROPYRIDINES; DIMETHYLPHENYLPIPERAZINIUM IODIDE; DOGS; FEMALE; MALE; MUSCARINE; NIFEDIPINE; NITROPRUSSIDE;

EID: 0031664129     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199809000-00020     Document Type: Article

References (26)

1. 2+ current recorded from the rabbit basilar artery. Circ Res 1990;67:993-1006.
2. Ikeda K, Hosono M, Iida H, Ohnishi H. Antihypertensive and cardiovascular profiles of a newly synthesized dihydropyridine derivative 2-methoxyethyl (E)-3-phenyl-2-propen-1-yl(±)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl) pyridine-3,5-dicarboxylate (FRC-8653). Pharmacometrics 1992;44:433-42.
3. Hosono M, Hiruma T, Watanabe K, et al. Inhibitory effect of cilnidipine on pressor response to acute cold stress in spontaneously hypertensive rats. Jpn J Pharmacol 1995;69:119-25.
4. Hosono M, Fujii S, Hiruma T, Watanabe K, et al. Inhibitory effect of cilnidipine on vascular sympathetic neurotransmission and subsequent vasoconstriction in spontaneously hypertensive rats. Jpn J Pharmacol 1995;69:127-34.
5. ++ channel in rat dorsal root ganglion neurons. J Pharmacol Exp Ther 1997;280:1184-91.
6. 2+ channels in evoked release of norepinephrine from sympathetic neurons. Science 1988;239:57-61.
7. Rittenhouse AR, Zigmond RE. ω-Conotoxin inhibits the acute activation of tyrosine hydroxylase and the stimulation of norepinephrine release by potassium depolarization of sympathetic nerve endings. J Neurochem 1991;56:615-22.
8. Gandia L, Borges R, Albillos A, Garcia AG. Multiple calcium channel subtypes in isolated rat chromaffin cells. Pflugers Arch 1995;430:55-63.
9. Kimura T, Takeuchi A, Satoh S. Inhibition by ω-conotoxin GVIA of adrenal catecholamine release in response to endogenous and exogenous acetylcholine. Eur J Pharmacol 1994;264:169-75.
10. Harish OE, Kao LS, Raffaniello R, Wakade AR, Shneider AS. Calcium dependence of muscarinic receptor-mediated catecholamine secretion from the perfused adrenal medulla. J Neurochem 1987;48:1730-5.
11. Nakazato Y, Ohga A, Oleshanskly M, Tomita U, Yamada Y. Voltage-independent catecholamine release mediated by the activation of muscarinic receptors in guinea-pig adrenal glands. Br J Pharmacol 1988;93:101-9.
12. Kimura T, Shimamura T, Satoh S. Effects of pirenzepine and hexamethonium on adrenal catecholamine release in responses to endogenous and exogenous acetylcholine in anesthetized dogs. J Cardiovasc Pharmacol 1992;20:870-4.
13. + channels of muscarinic responses in cat chromaffin cells. Am J Physiol 1994; 266:C1432-9.
14. Kimura T, Katoh M, Satoh S. Inhibition by opioid agonists and enhancement by antagonists of the release of catecholamines from the dog adrenal gland in response to splanchnic nerve stimulation: evidence for the functional role of opioid receptors. J Pharmacol Exp Ther 1988;244:1098-102.
15. Ca channels modulate adrenal catecholamine release in anesthetized dogs. Eur J Pharmacol 1997;327:135-41.
16. 2 receptors with nicotinic receptors. J Pharmacol Exp Ther 1991;257:369-73.
17. Cheek TR, Burgoyne RD. Effect of activation of muscarinic receptors on intracellular free calcium and secretion in bovine chromaffin cells. Biochim Biophys Acta 1985;846:167-73.
18. 2+ uptake. Neurosci Lett 1988; 87:266-70.
19. 2+. Neurosci Lett 1988;90:338-42.
20. Akaike A, Mine Y, Sasa M, Takaori S. Voltage and current clamp studies of muscarinic and nicotinic excitation of the rat adrenal chromaffin cells. J Pharmacol Exp Ther 1990;255:333-9.
21. Inoue M, Kuriyama H. Muscarinic receptor is coupled with a cation channel through a GTP-binding protein in guinea-pig chromaffin cells. J Physiol (Lond) 1991;436:511-29.
22. Hillarp NA, Hökfelt B. Evidence of adrenaline and noradrenaline in separate adrenal medullary cells. Acta Physiol Scand 1953;30:55-68.
23. Sim MK, Manjeet S. Properties of muscarinic receptors mediating second messenger responses in the rabbit aorta. Eur J Pharmacol 1990;189:399-404.
24. Rand VE, Garland CJ. Endothelium-dependent relaxation to acetylcholine in the rabbit basilar artery: importance of membrane hyperpolarization. Br J Pharmacol 1992;106:143-50.
25. Su J, Renaud N, Carayon A, Crozatier B, Hittinger L. Effects of the calcium channel blockers, diltiazem and Ro 40-5967, on systemic haemodynamics and plasma noradrenaline levels in conscious dogs with pacing-induced heart failure. Br J Pharmacol 1994;113:395-402.
26. Kailasam MT, Parmer RJ, Cervenka JH, et al. Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomie function in human hypertension. Hypertension 1995;26:143-9.